Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 1403 The EIF4 translational in...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
1403 The EIF4 translational inhibitor pateamine a improves immunological and neurological functions in BXSB.yaa lupus mice

1403 The EIF4 translational inhibitor pateamine a improves immunological and neurological functions in BXSB.yaa lupus mice

Bibliographic Details
Main Authors: Marta E Alarcón-Riquelme, Guillermo Barturen, Nieves Varela, Harini Bagavant, Maria Morell, Gonzalo Gómez-Hernández
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Lupus Science and Medicine
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • PO.1.4 The eIF4 translational inhibitor pateamine a improves immunological and neurological functions in BXSB.Yaa lupus mice
    by: M Morell, et al.
    Published: (2022-10-01)
  • Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice.
    by: Shweta Jain, et al.
    Published: (2016-01-01)
  • Potent anti-coronaviral activity of pateamines and new insights into their mode of action
    by: Francesca Magari, et al.
    Published: (2024-07-01)
  • (NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus
    by: Ruqayyah J. Almizraq, et al.
    Published: (2022-09-01)
  • 1205 Treatment of Lupus-prone BXSB Mice with a Modulatable CAR T cell System Targeting CD19
    by: Travis S Young, et al.
    Published: (2022-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs